As a transcription factor, CMTM2 expression was downmodulated in HCC tissues, and low CMTM2 expression was associated with the poor prognosis of HCC patients, suggesting a potential tumor suppressor role of CMTM2 in HCC progression 24. Here, CMTM2 is linked to hepatocellular carcinoma.